secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0000313143-24-000015
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics announces Q4 and FY2024 financial results; details not available in this filing
--------------------------------------------------------------------------------

- Press release dated May 9, 2024, reports results for quarter and fiscal year ended March 30, 2024.
- Specific financial figures (EPS, revenue, guidance) are not included in the provided filing text.
- The release may contain material operational updates, but cannot be summarized without exhibit content.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314324000015/0000313143-24-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314324000015/hae-20240509.htm
  HTML page:      https://secwatch.observer/filing/0000313143-24-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer